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Abstract 
 Traumatic brain injury (TBI) is a worldwide public 
health problem and an important cause of 
hypopituitarism.  The incidence of hypopituitarism 
following moderate to severe TBI varies in different 
studies and may occur as multiple or isolated hormonal 
deficiencies, with gonadotrophin and growth hormone 
insufficiencies predominating, particularly in the acute 
setting.  Adrenocorticotropic hormone deficiency is also 
common during the recovery phase.  Pituitary function 
assessment in the acute phase post TBI is subject to 
multiple caveats and pitfalls due to hormonal alterations 
which occur as normal physiological responses to 
critical illness and the effects of drugs that are used in 
the intensive care unit. Nonetheless, assessment of the 
hypothalamo-pituitary-adrenal axis is of paramount 
importance during this period.  Predictors of 
hypopituitarism during the acute phase of TBI remain 
unclear - further research is warranted.  
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Introduction 
 Traumatic brain injury (TBI) is a major public 
health problem worldwide as it is the principal cause of 
death and disability among young adults, resulting in 
physical, emotional, social, cognitive and behavioural 
impairments, leading to poor quality of life.1-3  The most 
common causes of TBI include motor vehicle accidents, 
violence, sport injuries, falls and child abuse.  Children 
younger than 4-5 years of age, young adults (aged 15-24 
years) and the elderly (older than 65 years of age) are the 
age groups most at risk.2-3   
 Hypopituitarism is becoming an increasingly 
recognized complication following TBI, ranging from 
total to isolated deficiencies.2  It can occur in the acute, 
post-acute recovery or chronic phase (after 1 year).  
Prevalence of hypopituitarism varies widely between 
studies, possibly due to differences in inclusion criteria, 
dynamic tests employed, timing of testing post TBI and 
choice (if any) of confirmatory tests following 
identification of abnormal results.1  A pooled prevalence 
of 27.5% was reported in a systematic review evaluating 
pituitary function 3 months to 7 years post-TBI.  Patients 
suffering from severe TBI had a higher incident rate of 
hypopituitarism compared with those sustaining mild or 
moderate injury.4  Hypopituitarism post TBI is a 
dynamic process1,4, in which adrenocorticotropic 
hormone (ACTH) deficiency can represent a life-
threatening pathology, particularly during the acute 
phase.  
 
Methods 
 We performed a Medline/Trip database search to 
identify relevant studies or systematic reviews on this 
topic.  Search terms used were the various combinations 
of 'traumatic brain injury/'head injury'/'brain 
injury'/'trauma'/'injury’,,'pituitary'/'hypopituitarism'/'pitui
tary dysfunction', ‘pathophysiology’ and ‘assessment’.  
The search was conducted in December 2014.  Case 
reports, case series and non-original research 
publications were not included.  Articles were included 
regardless of the date of publication.  
 
Pathophysiology 
 Primary injury may lead to hypothalamo-pituitary 
dysfunction by direct mechanical damage to the pituitary 
gland, pituitary stalk and hypothalamus (table 1). The 
pituitary gland is particularly vulnerable to mechanical 
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injury/swelling as it lies within the confined space 
between the sella turcica and diaphragma sella, and is 
joined to the hypothalamus by a stalk.5 The 
hypothalamo-pituitary axis may also suffer from 
secondary injury through multiple mechanisms (table 1). 
Of note, if the stalk is damaged at the point of 
attachment to the hypothalamus leaving the rest of the 
stalk and its vessels intact, anterior pituitary infarction 
does not occur.3 
 
 
Table 1: Mechanisms of hypothalamo-pituitary injury.2-3, 5, 7, 26 
 
Type of injury 
 
Mechanism 
 
Primary injury 
 
- Fractures through sella turcica/skull base 
- Rotational/shearing injuries (including rupture of pituitary stalk) 
- oedema 
 
 
Secondary injury 
 
- skull fracture 
- haemorrhage 
- oedema/brain swelling 
- raised intracranial pressure 
- hypotension 
- anaemia 
- hypoxia 
- inflammatory 
- vasospasm 
- thrombosis 
-reperfusion injury 
-denervation (supraoptic and paraventricular nuclei, pituitary stalk or axon terminals in 
the neurohypophysis, leading to diabetes insipidus) 
- inflammatory mediators (e.g. nitric oxide, cytokines, free radicals, N-methyl-D-
aspartate) 
-autoimmunity (anti-pituitary antibodies) 
 
 Following an ischaemic insult, re-perfusion causes 
excitotoxicity and oxidative stress which, along with the 
surrounding inflammation, leads to neuronal cell death 
through necrosis or apoptosis.6  Acute hormonal 
deficiencies, particularly growth hormone (GH) 
(involved with vascular tone and brain repair processes) 
and insulin-like growth factor-1 (IGF-1) (important for 
myelination and prevention of oligodendrocyte 
apoptosis) may adversely affect repair after TBI. 
Recurrent mild TBI e.g. contact sports, effects of 
sedative/anaesthetic agents (such as etomidate and 
propofol) and the stress of critical illness (transiently 
suppressing the hypothalamo-pituitary axis) are other 
mechanisms leading to hypothalamo-pituitary 
dysfunction.5  
 Dysfunction/infarction of the posterior pituitary is 
less common than that of the anterior pituitary.  This is 
because vascularisation of the posterior pituitary derives 
from the short/inferior hypophyseal vessels (arising 
below the diaphragma sella), while the anterior 
pituitary’s blood supply, namely the long hypophyseal 
vessels (arising from the subarachnoid space and 
traversing the diaphragma sella) and portal capillaries in 
the pituitary stalk, are far more susceptible. Moreover, 
somatotrophs and gonadotrophs, located in the lateral 
regions of the anterior pituitary (vascularised by the long 
hypophyseal vessels), are much more susceptible to 
damage than the medially located corticotrophs and 
thyrotrophs (vascularised by short hypophyseal 
vessels).2,5 
 The syndrome of inappropriate anti-diuretic 
hormone secretion (SIADH) may develop secondary to 
cytokine (especially interleukin-6) induced stimulation 
of vasopressin release.7  Diabetes insipidus (DI) occurs 
if the posterior pituitary gland becomes denervated 
secondary to injury to the paraventricular and supraoptic 
hypothalamic nuclei, pituitary stalk or axon terminals in 
the neurohypophysis.  Additionally, reversible DI may 
complicate transient inflammatory oedema surrounding 
the hypothalamus and the neurohypophysis.3  
 
Incidence of Hypopituitarism in the acute and 
recovery phase of moderate to severe TBI 
 In the acute phase of moderate to severe TBI, Agha 
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A et al reported that 80% of patients suffered from 
gonadotrophin deficiency, 18% had GH deficiency, 16% 
glucocorticoid deficiency, 2% thyroid stimulating 
hormone (TSH) deficiency8-9, while cranial DI occurred 
in 26%.9   DI occurred in 22 out of 102 consecutive 
patients presenting with TBI.10  In a study by Tanriverdi 
et al, 56.5% of individuals had at least one axis affected 
in the acute phase.  36.9% had isolated hormonal 
dysfunction, 19.6% suffered from combined hormonal 
deficiencies, while none had panhypopituitarism.  These 
authors reported no significant difference in anterior 
pituitary hormone levels between individuals with mild, 
moderate and severe TBI in the acute phase, with the 
exception of total testosterone, which was much lower 
among those suffering from severe injury.  The most 
common deficiencies were gonadotrophin deficiency 
(41.6%) followed by GH deficiency (20.4%).11 
 The reported  incidence of hypopituitarism in the 
recovery phase post moderate to severe TBI varies in 
different studies, as summarised in table 2.  In a study by 
Bondanelli et al, 30.5% had at least one pituitary axis 
affected and 1.4% suffered from panhypopituitarism.12  
There was no association between  incidence of 
hypopituitarism and severity of TBI in some studies 6,12-
13, while an association was noted in others.10, 14  GH and 
gonadotrophin deficiencies predominated in some 
studies 6,12, while ACTH and gonadotrophin deficiencies 
predominated in others 8,13-14, as outlined in table 2. 
 The incidence of hypopituitarism in the 
chronic/recovery phase post TBI was reported as 35.3% 
following severe TBI and 10.9% following moderate 
TBI in a systematic review.4  New onset deficiencies 
were seen within the first six months (particularly 
ACTH deficiency), but not subsequently.  In most 
instances, there was a tendency towards amelioration in 
pituitary function with time4,8, with the majority of 
patients showing complete recovery of 
hyperprolactinaemia and the gonadotrophin axis.  
Patients with more severe GH and cortisol deficiency 
during the acute phase were more likely to remain 
deficient in these two hormones during recovery.8   
 In a prospective study by Kaulfers et al, moderate 
to severe TBI in children was associated with  pituitary 
dysfunction in 15% of affected individuals at 1-5 weeks, 
25% at 2-3 months, 75% at 6 months and 29% at 12 
months.  Pituitary function generally recovered within a 
year of TBI.  Pituitary hormonal impairment persisting 
thereafter was isolated, with precocious puberty being 
the most common (14%), followed by central 
hypothyroidism (9%) and GH deficiency (5%).15   
 
Assessment of pituitary function in the acute phase 
post-TBI 
 Several caveats and pitfalls must be considered when 
assessing pituitary function in the acute phase post TBI.   
Anaesthetic drugs (such as etomidate, pentobarbital and 
propofol) can induce adrenal insufficiency.  Vasopressors 
(such as dopamine agonists) can cause 
hypoprolactinaemia.5  Anticonvulsants, sedatives (such as 
midazolam) and narcotic analgesics (such as morphine and 
fentanyl) can also affect corticosteroid metabolism or 
suppress the hypothalamic-pituitary-adrenal axis.16-17  
Hepatic enzyme inducing anticonvulsants, such as 
carbamazepine or oxcarbazepine, can decrease circulating 
thyroid hormone in 25-50% of patients (TSH remaining 
stable) as well as increase the production of sex hormone 
binding globulin (SHBG) and/or increase breakdown of 
gonadal hormones, leading to low levels of free gonadal 
steroids.18    
 An increase in the stress hormones (GH, ACTH, 
cortisol, vasopressin and prolactin) may occur post-
TBI.18  In polytrauma patients, GH may be normal to 
low due to reduced secretory pulse amplitude.19  
However, peripheral GH resistance can occur in critical 
illness, leading to high GH and low IGF-1.7  Moreover, 
acute illness causes changes in hormone binding 
proteins.  Alterations in serum albumin and a lowering 
of cortisol binding globulin (CBG) concentration occur 
in the first week, causing higher circulating levels of free 
cortisol albeit a low total cortisol which will not reflect 
free and bioavailable cortisol.4,18 High cytokine levels 
increase corticosteroid metabolism (lowering free 
cortisol levels), decrease corticosteroid receptors and 
cause peripheral resistance to glucocorticoids, leading to 
‘relative adrenal insufficiency’.19  On the other hand, 
metabolism of circulating hormones may be reduced by 
damage or decrease in blood flow of organs/tissues 
responsible for their metabolism, often leading to higher 
circulating levels.  Diurnal rhythms are often disturbed.20  
 Central hypogonadism and hypothyroidism will 
occur in most patients, which may be indistinguishable 
from post traumatic central hypothyroidism and 
hypogonadism.18  A drop in tri-iodothyronine (T3) (low 
T3 syndrome) is observed due to decreased peripheral 
conversion of thyoxine (T4) to T3.  T4 and TSH may 
remain normal or fall acutely especially following severe 
injuries.7, 21  
As a result, whether free or total hormone measurements 
are taken, interpretation of such measurements is 
unreliable in the acute phase of TBI.  Moreover, a 
standard Synacthen test does not exclude cortisol 
deficiency, as the adrenal glands have not yet atrophied 
in the acute phase and will respond to exogenous ACTH, 
rendering this test dangerously misleading.  An insulin 
tolerance test (ITT) is relatively contraindicated and 
dangerous in this setting due to a risk of inducing 
seizures.18, 20 
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Table 2:  Incidence of hypopituitarism in the recovery phase of patients who had suffered from moderate to severe TBI in 
different studies. 
 
 
Study 
 
Time to 
testing 
 
Hypopituitarism 
affecting at least 
one anterior 
pituitary 
hormone 
 
 
Isolated 
anterior 
pituitary 
deficiencies 
 
Multiple 
anterior 
pituitary 
deficiencies 
 
Pituitary hormonal deficiencies 
GH FSH/ 
LH 
ACTH TSH PrL DI 
Dimopoulou 
et al 14 
Early 
recovery 
phase after 
weaning 
from 
mechanical 
ventilator 
53% 35% 18% ( two 
axes 
affected) 
9% 
(partially 
impaired 
on GHRH 
testing) 
24% 24% 
(post 
CRH 
testing) 
15% U/A U/A 
Agha et al 8 6 months U/A U/A U/A 13% 23% 19% 2% U/A U/A 
Agha et al 8 12 months U/A U/A U/A 10% 13% 19% 2% U/A U/A 
Agha et al 13 6-36 
months 
(median 17 
months) 
28.4% 22.5% 5.9% 10.7% 11.8% 12.7% 1% U/A U/A 
Agha et al 10 6-36 
months 
(median 17 
months) 
U/A U/A U/A U/A U/A U/A U/A U/A 6.9% 
Popovic et al 
6 
1 year 34% 24% 10% 15%- 
severe 
deficiency 
15%- 
insufficient 
9% 7% 4% 7% 4.5% 
Bondanelli et  
al 12 
6 months 
to 1 year 
26.4% 19.4% 5.5% 14% 14% 4% 4% U/A 1.4%* 
FSH- Follicle stimulating hormone; LH- Luteinizing hormone; ACTH- adrenocorticotropic hormone; TSH- Thyroid stimulating hormone; PrL- 
Prolactin; CRH- Corticotropin releasing hormone; GHRH- Growth hormone releasing hormone; U/A-unavailable *isolated 
 
 Since the endocrine response in the acute phase 
post TBI is markedly dynamic, taking regular hormonal 
measurements is acceptable in a bid to detect evolving 
endocrine pathology.  However, this approach is likely 
to increase the risk of  false positive results, rates of 
which are influenced by the accuracy of the specific 
assay employed for diagnostic purposes.20  Given that 
adrenal insufficiency is life threatening and dynamic 
testing is impractical in critically ill patients, daily early 
morning cortisol should be measured for the first seven 
days following brain injury.3,19  One-off measurements 
are unreliable as acute hypopituitarism may be transient, 
occur unpredictably in the first seven to ten days after 
TBI and may be self-resolving.19  In the absence of any 
glucocorticoid supplementation, a morning cortisol of 
less than 200nmol/L, is highly indicative of 
glucocorticoid insufficiency and the patient should be 
given intravenous hydrocortisone.  If the early morning 
cortisol level lies between 200 and 500nmol/L, and the 
patient shows features of adrenal insufficiency a trial of 
glucocorticoid replacement should be initiated.3-4,8  
Other reviews recommend treatment when the morning 
cortisol level is below 300nmol/L.1,19  Gonadal, thyroid 
and GH assessment in the acute phase is not essential, as 
replacing these hormones during critical illness has not 
been shown to improve outcomes; moreover any 
changes are likely to be adaptive responses to critical 
illness.3,19   Cranial DI can be diagnosed using Seckl and 
Dunger criteria.22  Similarly, SIADH is diagnosed using 
established clinical guidelines.23 
                                                                                                        
Assessment of pituitary function in the 
recovery/chronic phase 
 Assessment should commence by taking a complete 
history and examination to assess for hypopituitarism 
and hyperprolactinaemia.  Table 3 demonstrates the 
various signs and symptoms associated with 
hypopituitarism.    Hyperprolactinaemia may cause 
galactorrhoea and symptoms of gonadotrophin 
deficiency.  A serum sodium and a blood glucose will 
41
dRe 
 
  
Review Article  
 
 
Malta Medical Journal    Volume 27 Issue 04 2015                                                                                                                
 
 
help to exclude hyponatraemia and hypoglycaemia 
respectively, as seen in ACTH deficiency 
(hyponatraemia may also be seen in TSH deficiency).  
Hypernatraemia or a serum sodium towards the upper 
end of normal may be found in DI.  Pituitary function 
tests should include basal serum 7-9am  cortisol (if low, 
a serum ACTH should be requested), T4, T3 and TSH 
levels, luteinizing hormone, follicle stimulating 
hormone, oestradiol and SHBG, prolactin, IGF-1 and 
paired urine and plasma osmolalities.  A basal cortisol of 
less than 100nmol/L indicates adrenal insufficiency, 
while more than 400nmol/L indicates adequate function 
of the hypothamo-pituitary-adrenal axis.  If the basal 
cortisol lies between 100 and 400 nmol/L and/or GH 
deficiency is suspected, an ITT or glucagon stimulation 
test is recommended.  GH releasing hormone and the 
arginine/GH releasing peptide provocative test constitute 
two alternative dynamic tests of GH reserve.  Magnetic 
resonance imaging should be carried out (unless 
organised earlier) if the above tests indicate the 
possibility of hypothalamic-pituitary dysfunction.24-25   
 
 
Table 3:  Signs and symptoms associated with the various hormonal deficiencies present in hypopituitarism.2, 21, 27 
 
 
Hormone deficiency 
 
History 
 
Examination 
 
ACTH Lethargy, weakness, myalgia, 
nausea, anorexia, weight loss 
Pallor, hypotension 
Gonadotrophins decreased libido, dyspareunia, 
amenorrhoea/oligomenorrhoea 
Fine wrinkles, breast atrophy, 
paucity of body hair 
TSH Weight gain, cold intolerance, 
constipation, fatigue, low mood 
Dry skin, slow relaxing reflexes, 
bradycardia 
GH Impaired concentration, memory 
and cognitive function, low mood, 
reduced exercise tolerance 
Central adiposity, reduced lean 
mass 
Vasopressin Polyuria and polydipsia especially 
nocturnal 
 
 
Conclusion 
 The investigation and management of pituitary 
dysfunction in the acute phase post TBI remains 
challenging, particularly given the paucity of good 
quality research data. Well designed studies are needed 
to identify possible predictors of permanent 
hypopituitarism /pituitary dysfunction, while guiding the 
most appropriate timing and dosing of hormonal 
replacement in an intensive care/acute setting.  
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